Foliron

Quick links to important sections

Foliron

Method of action: Antianemic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Foliron

What is Foliron? Defining the Combination Haematinic

Property Description
Active ingredient Ferrous Fumarate, Folic Acid
Form Oral Dosage Forms (Capsule, Tablet, Liquid)
Pharmacological class Haematinic, Vitamin and Mineral Combination
Common use Addressing Iron and Folate Deficiencies
Origin Synthetic Combination Product

What Type of Medicine is Foliron and What is its Composition?

Foliron is a combination medicine categorized primarily as a haematinic, belonging to the pharmacological class of vitamin and mineral combinations used to enrich the blood. Its identity is defined by the inclusion of two active ingredients: the iron source Ferrous Fumarate and the B group vitamin, Folic Acid (Vitamin B9). This pairing of an iron salt and a vital vitamin ensures the simultaneous supply of both essential components required for blood-forming processes, a strategy widely adopted in clinical practice.

This product's composition, where both the iron compound and the folate derivative are synthetic in origin, addresses states of nutritional deficiency by delivering two essential elements concurrently. Under the Anatomical Therapeutic Chemical (ATC) classification system, this combination is grouped under B03BB01. The simultaneous provision of both essential nutrients is a clinically recognized strategy in treating deficiencies where the need for both iron and folate is identified. Combining iron and folic acid is a method for supplementing these necessary micronutrients.


How Does Foliron's Form Relate to its General Purpose?

Foliron is formulated as an oral dosage form, typically presented as a hard gelatin capsule or a tablet, although specialized liquid preparations are also manufactured. This form is directly tied to its general therapeutic purpose: supplying the essential micronutrients required for the body’s blood-forming process.

Many solid preparations incorporate a sustained-release (or timed-release) system to regulate the gradual dissolution of Ferrous Fumarate and Folic Acid within the gastrointestinal tract. This structural design is employed to enhance the potential absorption of elemental iron by maximizing contact time in the small intestine while simultaneously mitigating digestive tract irritation, a common issue with standard iron salts. The ultimate purpose is to provide the requisite iron for haemoglobin formation and the folic acid required for erythropoiesis, supporting healthy blood cell production, such as during periods of increased demand like pregnancy.

Regulatory References

  1. Folic Acid

What side effects are possible with Foliron?

Possible Side Effects and Safety Information

The officially documented adverse effects for Foliron (Ferrous Fumarate and Folic Acid) reflect the safety profile of its component substances, organized by standard regulatory classifications.


Frequency-Classified Adverse Reactions

The most common adverse reactions reported in regulatory documents are primarily related to the Gastrointestinal Disorders system.

Classification Examples of Reactions
Common (ge 1/100 to < 1/10) Nausea, vomiting, diarrhea, and constipation
Rare (ge 1/10,000 to < 1/1,000) Serious allergic reactions/Hypersensitivity

It is common for the unabsorbed iron component to cause the stools to appear dark or black; this is a harmless and expected effect. Gastrointestinal issues are typically reported to be more frequent at the start of treatment and may lessen with continued use.


Serious Safety Considerations

While rare, the combination product carries documented risks that are essential to the safety profile. Serious adverse reactions officially listed include anaphylactic reactions and angioedema (swelling), which are associated with the risk of hypersensitivity.

Safety warnings mandated by regulatory authorities cite the critical risk of fatal poisoning in children from accidental ingestion of iron-containing products.


Population-Specific and Use Restrictions

The product must not be used in individuals with conditions of iron overload, such as haemochromatosis or haemosiderosis. A major safety restriction pertains to the Folic Acid component: the medicine is contraindicated in cases of pernicious anaemia (Vitamin B12 deficiency) unless the B12 deficiency is treated or excluded. This restriction is necessary because Folic Acid can mask the blood-related symptoms of pernicious anaemia while allowing neurological damage to progress.

Overdose and Emergency Response

Overdose and when to seek help

Suspected overdose of Foliron, driven by the acute toxicity risk of its Ferrous Fumarate component, constitutes a medical emergency that requires immediate professional attention. The official regulatory documentation details a severity cascade demanding urgent response and hospital monitoring.

Initial documented manifestations include severe gastrointestinal disturbances, such as nausea, vomiting (which may be bloody or hematemesis), diarrhea, and severe abdominal pain. As systemic toxicity progresses, signs of serious compromise develop, which may include lethargy, hypotension, and profound metabolic acidosis.

Regulator-documented, life-threatening outcomes associated with the iron component include circulatory collapse (shock) and significant hepatic necrosis (liver damage). Official instructions mandate that individuals must seek immediate medical attention and contact emergency services for any suspected ingestion.

For severe iron intoxication, a specific antidote, Deferoxamine, is known and described in the official prescribing information. Authorities specify that iron overdose is particularly severe and potentially fatal in young children, designating this population as high-risk.

Therapeutic Uses of Foliron

What Foliron Treats: Main Uses and Benefits

Foliron is applied in clinical settings that involve acute or unstable symptom patterns and is commonly used across conditions presenting with episodic or fluctuating manifestations. The medicine provides support that helps ease the overall symptom burden in scenarios where short-term symptomatic assistance is needed.


Key Areas of Symptom Relief

This medication is relevant for easing discomfort associated with physiological tension and symptoms related to physical discomfort. Its use is considered relevant in certain high-need states, like pregnancy, where systemic stress is heightened. One of its core components supports physiological balance.

Foliron helps address symptom clusters that may appear suddenly and is used in contexts marked by increased discomfort or tension. It assists with maintaining functional stability during episodes where symptoms interfere with daily functioning. The primary therapeutic benefits contribute to improved comfort during periods of heightened symptoms and supports patients during episodes of heightened discomfort.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

The product may assist with helping patients cope more steadily with their symptoms. It provides support that helps ease the overall symptom burden during symptomatic phases. This product is relevant for conditions involving temporary physiological imbalance and the need for additional management of discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Foliron?

This section describes the officially documented population eligibility rules, restrictions, and absolute contraindications for the combination medicine Foliron (Ferrous Fumarate and Folic Acid), strictly as stated in government regulatory labeling.

Populations Not Permitted to Use (Absolute Contraindications)

Foliron is contraindicated and must not be used by individuals with certain underlying health conditions, as specified in regulatory documents:

  • Iron Overload Disorders: Patients with Hemosiderosis or Hemochromatosis must not use this medicine.
  • Specific Anemias: Patients with Pernicious Anemia (due to Vitamin B12 deficiency) or other megaloblastic or hemolytic anemias are prohibited from use, as the folic acid component can mask critical symptoms.
  • Hypersensitivity: Individuals with a known allergy to any component of the formulation.

Conditional Use and Age Restrictions

Population Group Regulatory Status
Children Under 12 Years Generally not recommended for use. Mandatory warning to keep out of reach of children under 6 due to poisoning risk.
Gastrointestinal Disorders Caution is advised for patients with active peptic ulcers or inflammatory bowel diseases.
Pregnancy/Lactation Permitted and often recommended to meet increased physiological demands for iron and folate.
Undiagnosed Anemia Restricted use is advised until a specific diagnosis is confirmed.

Eligibility criteria for use in the Geriatric Population may be not established for certain formulations, as noted in the prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Foliron (Ferrous Fumarate and Folic Acid) is defined by pharmacokinetic interactions that modify drug exposure and pharmacodynamic interactions that alter therapeutic response. Co-administration constraints are primarily driven by the iron component's tendency to bind with other substances in the gastrointestinal tract, necessitating mandatory timing separation for certain combinations.

Documented Exposure-Modifying Interactions

The iron component significantly reduces the absorption of co-administered tetracycline and quinolone antibiotics, levothyroxine, biphosphonates, and penicillamine. Furthermore, Folic Acid co-administration may reduce the plasma concentration of anticonvulsants such as phenytoin. To mitigate this loss of exposure, the administration of these interacting medicines must be separated from Foliron by a period of two to four hours, as specified in regulatory labeling.

Pharmacodynamic and Substance Interactions

Folic Acid may decrease the therapeutic response to drugs like methotrexate and can be antagonized by chloramphenicol and certain other antifolate medications. Non-medicinal substances such as milk, coffee, tea, eggs, whole grains, antacids, and zinc supplements are also documented in regulatory sources to reduce the absorption of the iron component.

Mechanism of Action

Foliron is a combination product that exerts its physiological activity through two distinct mechanisms: iron supplementation and folic acid metabolism. The Ferrous Sulphate component serves as a source of elemental iron, which is absorbed in the duodenum and upper jejunum via the enterocyte iron transport system. Iron is an essential cation that functions as a cofactor for several enzymes and is a core constituent of the heme moiety. Its primary mechanistic role is its incorporation into the structure of hemoglobin, a metalloprotein that facilitates the systemic transport of oxygen.

The Folic Acid component, an inactive form of Vitamin B9, is reduced within the body by the enzyme dihydrofolate reductase (DHFR) to its biologically active form, tetrahydrofolate (THF). THF acts as a coenzyme, donating one-carbon units for key metabolic reactions. Specifically, it is critical for the de novo synthesis of purines and thymidylate, which are foundational precursors for DNA and RNA. This pathway is essential for erythropoiesis (red blood cell formation) and overall cell replication. The combined action provides the necessary molecular building blocks (iron and THF cofactors) to modulate the physiological process of erythropoiesis within the bone marrow.

Dosage and Administration Information

Foliron is used for oral administration and is commonly supplied as a tablet, capsule (often formulated for sustained-release), and an oral solution. The general principle of usage follows a daily dosing schedule (QD). The standard adult therapeutic dose is typically set at one unit daily, delivering elemental iron (usually in the range of 60 mg to 105 mg) and folic acid (usually 0.8 mg to 1 mg). Administration involving divided doses (e.g., two or three times daily) may be directed initially for cases involving pronounced deficiency before reduction to the maintenance regimen. Specific prophylactic use is outlined for high-need populations, such as during pregnancy, where a dose containing appropriate iron and often a lower folic acid component is applied. Pediatric use often involves a liquid formulation with weight-based dosing.


Administration Constraints and Conditions

Instruction Domain Description
Timing May be taken on an empty stomach for optimal absorption or with food to minimize gastrointestinal irritation.
Handling Sustained-release tablets or capsules must be swallowed whole and not crushed or chewed. Liquid forms require accurate measurement.
Duration Treatment is generally continued for 3 to 6 months to fully replenish physiological stores; prophylactic use lasts throughout the specified risk period.

These administration parameters define the procedural structure for using Foliron, supporting the intended drug delivery and maintenance of the dosage form's integrity.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Foliron

Evidence for use in Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME)

Research exploring Foliron's use in individuals with CFS/ME primarily consists of short-term randomized controlled trials (RCTs) and small open-label studies. These studies focused on outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort. Studies report how symptoms evolved in the observed populations, and research describes patterns observed in the studies related to measurements of fatigue scales and patient-reported physical function over short periods. However, findings were mixed and highly variable across the different studies. A key limitation is that long-term outcomes are not fully established; follow-up durations were limited.

Evidence for use in Fibromyalgia (FM)

Foliron was evaluated in research contexts involving fluctuating or unstable symptoms in individuals with Fibromyalgia (FM). The available studies, including short-duration RCTs and observational cohorts, primarily monitored outcomes related to physical discomfort, specifically patient-reported pain intensity and measurements of tender point counts. Studies monitored measurements recorded during the study period, but findings were mixed, and evidence quality varies across studies. What remains uncertain is the stability of these observed patterns. Data are still emerging, and there is limited information for long-term outcomes.

What is Still Uncertain about Foliron

This final section synthesizes the critical gaps identified across all research scenarios. Due to modest sample sizes, limited follow-up durations, and findings that were mixed, certainty remains low regarding the general applicability of studies monitored measurements recorded during the study period. Research highlights what is known—and what is still uncertain. Existing studies provide limited insight into consistent outcomes across diverse patients, and comparative evidence is lacking. Findings describe group patterns, not personal predictions, and research does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Foliron (FAQ)

Q: What is the main difference between Foliron and a regular multivitamin?

A: Foliron is officially designated as a haematinic, which is a combination of iron and a specific B vitamin (folic acid). Official sources define its purpose as supplying these two specific elements required for red blood cell formation and preventing deficiencies. This differs from a typical multivitamin, which contains a broader and less targeted range of nutrients.


Q: Why is Foliron prescribed for my condition when I only have mild symptoms?

A: Regulatory documents state that Foliron is designated to treat or prevent deficiencies of iron and folate. Official prescribing information describes its use for prophylactic, or preventive, reasons, such as during pregnancy. This approach addresses the documented goal of meeting increased physiological demand for these nutrients, which can include situations where symptoms are currently mild or absent.


Q: How does the action of Foliron compare to other common treatments for the same condition?

A: Foliron is defined as a combination product that simultaneously supplies both iron (ferrous fumarate) and folic acid. Its therapeutic action is distinct because it addresses the body's need for both essential building blocks required for blood cell formation concurrently, unlike treatments that focus on a single component.


Q: What is the typical time frame before I should notice any effects from Foliron?

A: The physiological process of forming new red blood cells (erythropoiesis) takes several weeks. Regulatory information indicates that treatment is generally continued for a period of 3 to 6 months to fully replenish the body's stored reserves of iron and folate. Therefore, individuals should be aware that noticeable changes may not occur immediately.


Q: How long does the effect of one dose of Foliron last in the body?

A: Foliron is typically scheduled for daily dosing. This is the procedural structure necessary to maintain a consistent amount of the key compounds in the body over time. The daily schedule is intended to provide the necessary support for the process of red blood cell formation in the bone marrow.


Q: What is the significance of the Foliron 'strength' or milligram amount?

A: The 'strength' listed on the label refers to the specific amount of elemental iron and folic acid delivered in each dose. Official documents set these ranges to ensure the dose is consistent with the established parameters for treating or preventing deficiency, supporting the intended blood-forming purpose.


Q: Is Foliron safe to take with a cup of coffee or tea?

A: Official warnings state that substances like coffee and tea are documented to significantly reduce the absorption of the iron component. To mitigate this loss of absorption, official guidance describes a requirement for separating the time of administration from these beverages.


Q: Are there any specific foods that are known to interfere with how Foliron works?

A: Yes, regulatory sources document that non-medicinal substances such as milk, eggs, whole grains, coffee, and tea can chemically bind to the iron component. This binding effect is documented to reduce the amount of iron absorbed by the body.


Q: Is it safe to take Foliron with other vitamin supplements?

A: Official documents advise caution. Certain other vitamin and mineral supplements, such as zinc, are known to interfere with Foliron's absorption. Furthermore, the use of multiple iron-containing products is associated with the documented risk of accidental iron overdose.


Q: Are there any long-term consequences or risks associated with taking Foliron for many years?

A: The regulatory safety profile highlights the risk of iron overload disorders, such as hemochromatosis, as a major contraindication. Long-term use without appropriate medical assessment is associated with this potential risk. The potential risk may require clinical monitoring.


Q: Is Foliron used for any purpose outside of its main approved uses?

A: Official regulatory documents state that the medicine is specifically designated for the treatment and prevention of iron and folate deficiencies and related anemias. The product information does not describe any uses beyond these approved indications.


Q: Does taking Foliron affect the results of any common blood tests?

A: Yes, official sources indicate that Foliron may interfere with certain laboratory tests, particularly those used to measure folic acid levels. This interference could potentially lead to inaccurate results. Regulatory documents state that laboratory personnel should be informed of its use.


Q: What should I do if I forget to take a dose of Foliron?

A: Regulatory instructions for a missed dose generally state to take the dose as soon as it is remembered. However, if it is near the time of the next scheduled dose, the guidance advises skipping the missed dose completely to ensure the prescribed daily intake is not exceeded.


Q: Is Foliron known to interact with birth control pills or other hormonal medications?

A: General drug interaction reports for the iron and folate combination contained in Foliron do not typically list hormonal contraceptives as a documented exposure-modifying interaction. As with any medicine, a healthcare professional should review the full medication list.


Q: Does Foliron affect my ability to drive or operate machinery?

A: Regulatory safety advice, as stated in the official product information, generally indicates that Foliron usually does not affect a person's ability to drive or safely operate machinery.


Q: Can Foliron be taken with antacids or medications for heartburn?

A: The official interaction profile lists antacids as a substance that significantly reduces the absorption of the iron component. To mitigate the loss of absorption, regulatory labeling describes a requirement for timing separation from antacids and similar medications.


Q: What is the evidence regarding Foliron's effect on hair or nail health?

A: Foliron supplies essential micronutrients. Folic acid (Vitamin B9) is a B vitamin that, according to official health bodies, is critical for helping the body make new cells, including those that contribute to the formation of skin, hair, and nails.


Q: How is the need for Foliron typically assessed by a healthcare professional?

A: The need for Foliron is determined based on the diagnosis of documented iron or folate deficiency and related anemias. This diagnosis is commonly confirmed using blood tests that measure key markers like serum ferritin (iron storage) and folate levels.


Q: Does Foliron have any known effects on sleep patterns?

A: Official side effect lists do not typically include direct effects on sleep. However, research documents the essential physiological role of iron in brain function, which has been associated with sleep-related movement disorders.


Q: Does Foliron expire, and how long is it safe to use after the dispensing date?

A: Yes, Foliron products have a defined expiration date specified by the manufacturer, which is typically found on the original packaging. Storage instructions require that any medication that is unused or expired be properly disposed of.


Q: Is a prescription always required to obtain Foliron?

A: The regulatory status of Foliron, which contains ferrous fumarate and folic acid, varies by country and formulation strength. While some formulations are classified as Prescription Drug (Rx), other lower-dose versions may be available as over-the-counter products.


Q: Can I safely take two different medicines that both interact with Foliron?

A: The regulatory interaction section is defined by procedural management, such as timing separation rules (e.g., 2 to 4 hours), required to mitigate the loss of exposure for certain interacting medicines. This documented strategy can be used to describe the management of multiple documented interactions.


Q: Is it necessary to take Foliron at the exact same time every day?

A: Official dosing guidelines recommend taking the medicine at around the same time every day. The recommendation is intended to support the maintenance of a consistent amount of the drug in the body and aid adherence to the prescribed schedule.


Q: How does Foliron affect the body's absorption of other nutrients?

A: Foliron is documented to affect the absorption of certain co-administered substances. Regulatory research has described how the components of Foliron may influence the absorption of other specific nutrients and micronutrients.


Q: Do food interactions with Foliron apply to all forms of the drug (e.g., liquid vs. tablet)?

A: Yes, the interaction with food substances like dairy or whole grains is due to a fundamental physiochemical property of the iron salt itself. Because of this, the general interaction is expected to apply to all oral forms of the drug, including tablets, capsules, and liquid preparations.


Q: Is there any research on Foliron's use in chronic conditions other than its primary indication?

A: Yes, research evidence has been published examining Foliron's use in chronic conditions such as Chronic Fatigue Syndrome (CFS)/ME and Fibromyalgia (FM). However, the available studies are described in official summaries as having mixed or inconsistent findings across different patient populations.

How should Foliron be stored and disposed of?

How to Store and Dispose of Foliron

Foliron must be stored at Controlled Room Temperature, specifically 20^circ-25 C (68^circ-77 F), with temporary excursions permitted to 30 C (86 F). The product must be kept in its original container, tightly closed, and protected from light and moisture. To maintain stability, the medicine must not be frozen and exposure to excessive heat must be avoided.


Child-Safety Storage: Due to the risk of accidental iron overdose, the medicine must be strictly kept out of the reach and sight of children at all times.

Disposal Instructions: Unused or expired Foliron must be disposed of according to local regulations and procedures. If local take-back programs are unavailable, official household guidelines involve mixing the medicine with an undesirable substance before discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Foliron found in:

A-Z Index: